Finance

Beta
Lists
016580:KRX
Whanin Pharm Co Ltd
₩10,240.00
+0.39%
(+40.00) 1D
Jun 12, 10:42:06 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 016580...
Open
₩10,260
High
₩10,300
Low
₩10,030
Mkt. cap
190.46B
Avg. vol.
70.92K
Volume
8.88K
Dividend
2.93%
Quarterly dividend
₩75
Ex-dividend date
Dec 27, 2023
P/E ratio
10.95
52-wk high
₩13,210
52-wk low
₩9,850
EPS
₩936
Shares outstanding
18.60M
No. of employees
634
Open
₩10,260
High
₩10,300
Low
₩10,030
Mkt. cap
190.46B
Avg. vol.
70.92K
Volume
8.88K
Dividend
2.93%
Quarterly dividend
₩75
Ex-dividend date
Dec 27, 2023
P/E ratio
10.95
52-wk high
₩13,210
52-wk low
₩9,850
EPS
₩936
Shares outstanding
18.60M
No. of employees
634
News stories
From sources across the web
About Whanin Pharm Co Ltd
CEOWon Beom Lee
Employees634
Founded1978
Headquarters-
SectorPharmaceutical industry
Websitewhanin.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
64.14B
65.74B
65.14B
71.18B
Cost of goods sold
43.12B
44.31B
41.64B
44.93B
Cost of revenue
43.12B
44.31B
41.64B
44.93B
Research and development expenses
165.04M
498.72M
251.09M
173.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.76B
16.48B
20.86B
15.87B
Operating expense
18.31B
17.87B
22.02B
16.87B
Total operating expenses
61.43B
62.18B
63.66B
61.79B
Operating income
2.70B
3.56B
1.48B
9.38B
Other non operating income
-13.89M
98.76M
70.26M
-441.28M
EBT including unusual items
3.44B
4.06B
1.73B
9.98B
EBT excluding unusual items
3.44B
4.06B
2.01B
9.97B
Income tax expense
249.20M
785.02M
-281.62M
2.52B
Effective tax rate
7.25%
19.33%
-16.28%
25.20%
Other operating expenses
549.95M
249.44M
322.59M
224.25M
Net income
3.19B
3.28B
2.01B
7.47B
Net profit margin
4.97%
4.98%
3.09%
10.49%
Earnings per share
-
-
-
-
Interest and investment income
363.52M
501.75M
456.44M
1.38B
Interest expense
-6.33M
-7.37M
-8.35M
-9.05M
Net interest expenses
357.19M
494.37M
448.10M
1.37B
Depreciation and amortization charges
230.47M
228.49M
219.37M
218.97M
EBITDA
5.16B
6.03B
3.93B
11.84B
Gain or loss from assets sale
2.00K
-498.00K
282.08M
-14.20M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer